Nirmatrelvir is an antiviral medication developed by Pfizer which acts as an orally active 3C-like protease inhibitor. [3][4][5][6][7] It is part of a nirmatrelvir/ritonavir combination used to treat …

Oct 7, 2025 · Nirmatrelvir in combination with another medicine called ritonavir is used for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to …

Jan 1, 2026 · Nirmatrelvir and ritonavir combination is used to treat mild to moderate coronavirus disease 2019 (COVID-19) in non-hospitalized patients who are at high risk for progression to …

Jun 26, 2024 · Paxlovid contains two medicines, nirmatrelvir and ritonavir. Nirmatrelvir is a medicine used against the virus that causes COVID-19. It works by preventing the virus from …

Apr 27, 2021 · Nirmatrelvir is an oral protease inhibitor with emergency use authorization for the treatment of mild-to-moderate COVID-19.

The PAXCESS® Patient Support Program may help eligible patients lower the cost of PAXLOVID® and access savings, with or without insurance. T&Cs apply.

We conducted a phase 2–3 double-blind trial to assess the efficacy and safety of nirmatrelvir–ritonavir in asymptomatic, rapid antigen test–negative adults who had been …

For the standard dose, take 2 pink tablets of nirmatrelvir with 1 white tablet of ritonavir (3 tablets total) by mouth with water twice daily. Talk to your care team if you have kidney disease.

Dec 22, 2021 · Nirmatrelvir–Ritonavir Nirmatrelvir is an oral inhibitor of SARS-CoV-2 protease that decreases viral replication. It is given in combination with ritonavir, an HIV protease inhibitor, …

The combination of nirmatrelvir and ritonavir is used to treat coronavirus disease 2019 (COVID-19 infection) caused by the SARS-CoV-2 virus in adults who have mild to moderate symptoms …